Aimei Health Technology Co., Ltd. 8-K

What Happened
Aimei Health Technology Co., Ltd. (AFJK) announced that on May 19, 2026 it received a notice from the Nasdaq Listing Qualifications Staff stating the company was not in compliance with Nasdaq Listing Rule 5250(c)(1) because it had not filed its Quarterly Report on Form 10‑Q for the period ended March 31, 2026 (the report was due May 15, 2026). The Notice does not have an immediate effect on the listing or trading of the company’s securities. Aimei issued a related press release on May 20, 2026 and said it is working to complete and file the Quarterly Report, but gave no assurance on timing.

Key Details

• Nasdaq Notice date: May 19, 2026; Quarterly Report due date: May 15, 2026.
• Company has 60 calendar days from the Notice to either file the Form 10‑Q or submit a compliance plan to Nasdaq.
• If Nasdaq accepts a submitted plan, the company could be given up to 180 calendar days from the original due date to regain compliance.
• If Nasdaq does not accept a plan, the company may appeal to a Nasdaq hearings panel. The press release was filed as Exhibit 99.1 on May 20, 2026.

Why It Matters
This is a regulatory compliance matter, not an immediate trading suspension. However, if Aimei fails to timely regain compliance, its Nasdaq listing could be at risk, which could reduce liquidity and make trading its shares more difficult. Investors should monitor filings for the eventual Form 10‑Q and any Nasdaq communications or updates from the company about its plan to regain compliance.